Classic Deal: HCA – Chris Gordon, Bain Capital (EP.335)

Episode Summary

Executive Summary: Chris Gordon recaps Bain Capital and KKR’s 2006 take-private of HCA, then traces how the deal was sourced, financed, negotiated, and managed through the financial crisis to a successful 2011 IPO. The discussion highlights the rise of mega-buyouts, the value of disciplined long-term ownership in healthcare, and lessons on operating improvements, capital structure management, and consortium execution.

Main Topics: Bain Capital’s evolution and the mid-2000s PE backdrop (Priority: 5/5): Gordon explains Bain Capital’s shift from a consulting spinout into a large multi-asset manager and places HCA in the context of a period when debt markets and firm capabilities were finally large enough to support mega-buyouts. HCA’s history and why it fit private equity (Priority: 5/5): HCA’s founding by the Frist family, prior public-private cycles, and its position as a scaled urban hospital platform made it attractive as a long-duration value creation opportunity. Sourcing and discreetly underwriting the take-private (Priority: 5/5): The team launched a tightly controlled feasibility study with the board, management, KKR, Merrill Lynch, and the Frist family, emphasizing confidentiality and staged financing commitments. Negotiating the deal and managing the consortium (Priority: 4/5): The transaction required multiple rounds of bargaining with a sophisticated board and careful alignment among Bain, KKR, Merrill Lynch, and the Frists to reach a price everyone could accept. Operating through the financial crisis (Priority: 5/5): After closing, HCA navigated the GFC by focusing on debt maturity management and operational improvements rather than radical transformation, while preserving the business’s resilient healthcare cash flows. IPO, exit, and investment performance (Priority: 4/5): HCA returned to public markets in 2011 via a large IPO, allowing Bain to de-risk the capital structure and ultimately realize about a 5x return. Lessons for healthcare investing and private equity (Priority: 4/5): Gordon emphasizes culture, long-term thinking, and incremental operational excellence as durable drivers of value, while noting the need to manage regulatory and capital structure risk.

Key Arguments: Mega-buyouts became possible when debt markets, fund sizes, and team capabilities all scaled together; HCA was a proof point at the edge of what the market believed was feasible. HCA was underappreciated by public markets because investors focused on short-term admissions and bad-debt volatility rather than long-term healthcare demand and platform quality. A narrow, trusted consortium and staged financing process were essential because the board needed certainty before approving a transaction of that size. The deal worked because all parties were aligned on long-term value creation, and the Frist family’s deep operational insight was central to the thesis. Public ownership created quarterly pressure, while private ownership let HCA move faster on operational changes and accept short-term volatility for long-term gains. The financial crisis did not break HCA because the balance sheet was structured prudently and the business was recession-insensitive enough to continue performing. Value creation came mostly from lots of small operational improvements, not a single grand transformation, especially centralizing best practices across hospitals. HCA’s IPO succeeded because Bain built a credible growth narrative and delivered real performance to support it; public investors rewarded that runway. Experienced investing through multiple cycles helped Bain avoid overextending in later market environments and reinforced the importance of hedging and maturity planning.

Data Points: HCA transaction enterprise value: $33 billion - Size of the 2006 take-private, described as the largest private equity transaction in history at the time. Bain Capital AUM: $165 billion - Bain’s size in the present day as described by Gordon. Bain Capital offices: 24 offices - Current global footprint of the firm. Bain Capital employees: about 1,600 employees - Current firm headcount. Bain Capital private equity share of AUM: a little over half - Private equity is the largest business line within Bain’s asset base. HCA operating footprint: 182 hospitals and 2,300 sites of care in 20 states and the UK - Current scale of the company as referenced in the introduction. Bain tenure of speaker: since 1997 (26 years) - Gordon’s experience at Bain Capital. Interview timeline: 16 or 17 years ago - Reference point for the HCA deal relative to the conversation date. Deal process duration: about 4 months - Approximate time from initial feasibility work to signing and going public. Equity syndicate participants: Bain Capital, KKR, Merrill Lynch, and the Frist family - Core equity backers of the transaction. Debt financing requirement: north of $20 billion - Amount of debt that needed to be underwritten for the purchase. Number of banks to fill debt: 3 additional banks - Beyond Merrill Lynch, three more banks were brought in to complete underwriting. Back-and-forth proposals: 2 or 3 concrete proposals - Negotiation rounds with the HCA board. IPO size: $4.5 billion - HCA’s 2011 public offering size. IPO price: $30 per share - Initial public market valuation at re-listing. Bain exit price range: around $75 per share - Approximate level at which Bain sold its last shares. Current HCA share price: mid to high $200s - Speaker’s reference to HCA’s later stock performance. Investment return: about 5x multiple of money - Bain’s total realized return on HCA. Interest rate hedging: over 95% of variable rate exposure - Portfolio-wide hedging Bain put in place in early 2021.

Pivotal Quotes: "To outperform the markets, you have to do something differently from others." — Intro / WCM testimonial: Opening framing for the episode’s sponsor message about differentiated investing. "Is it crazy to think that we could actually take HCA private again?" — Chris Gordon (recounting Tommy Frist Jr.): The call that initiated the feasibility study for the transaction. "success in business is not always about some grand transformative initiative... it's just about doing a lot of little things better" — Chris Gordon: Gordon’s key lesson on how HCA created value after the buyout.

Implications: The episode shows that large private equity outcomes often come from disciplined sourcing, cautious leverage, and operational compounding—not just bold moves. For healthcare investors, it underscores the importance of regulation resilience, culture, and capital structure planning across cycles.